- Home
- XENE vs RDN Comparison
XENE vs RDN Comparison
Compare XENE & RDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XENE | RDN |
|---|---|---|
| Founded | 1996 | 1977 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.5B |
| IPO Year | 2014 | 2008 |
Fundamental Metrics
Financial Performance| Metric | XENE | RDN |
|---|---|---|
| Price | $60.71 | $37.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $68.55 | $40.67 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.73% |
| EPS Growth | N/A | ★ 5.61 |
| EPS | N/A | ★ 0.89 |
| Revenue | $311,000.00 | ★ $1,197,084,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,496.48 | $2.66 |
| P/E Ratio | ★ N/A | $42.62 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $30.00 | $31.50 |
| 52 Week High | $62.91 | $38.84 |
Technical Indicators
Market Signals| Indicator | XENE | RDN |
|---|---|---|
| Relative Strength Index (RSI) | 74.22 | 69.36 |
| Support Level | $52.40 | $31.96 |
| Resistance Level | $62.91 | $38.59 |
| Average True Range (ATR) | 1.75 | 0.74 |
| MACD | 0.93 | 0.36 |
| Stochastic Oscillator | 93.36 | 96.13 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About RDN Radian Group Inc.
Radian Group Inc is engaged in mortgage and real estate services. It provides both credit-related mortgage insurance coverage and other products and services across the residential real estate and mortgage finance industries. It has one reportable segment, Mortgage Insurance, which primarily derives its revenue by providing private mortgage insurance on residential first-lien mortgage loans to mortgage lending institutions and mortgage credit investors.